Skip to main content

Bioavailability and Health Effects of Dietary Flavonols in Man

  • Conference paper
Diversification in Toxicology — Man and Environment

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 20))

Abstract

Flavonoids are polyphenolic compounds that occur ubiquitously in foods of plant origin. Over 4000 different flavonoids have been described, and they are categorized into flavonols, flavones, catechins, flavanones, anthocyanidins, and isoflavonoids. Flavonoids have a variety of biological effects in numerous mammalian cell systems, as well as in vivo. Recently much attention has been paid to their antioxidant properties and to their inhibitory role in various stages of tumour development in animal studies.

Quercetin, the major representative of the flavonol subclass, is a strong antioxidant, and prevents oxidation of low density lipoproteins in vitro. Oxidized low density lipoproteins are atherogenic, and are considered to be a crucial intermediate in the formation of atherosclerotic plaques. This agrees with observations in epidemiological studies that the intake of flavonols and flavones was inversely associated with subsequent coronary heart disease. However, no effects of flavonols on cancer were found in these studies.

The extent of absorption of flavonoids is an important unsolved problem in judging their many alleged health effects. Flavonoids present in foods were considered non-absorbable because they are bound to sugars as β-glycosides. Only free flavonoids without a sugar molecule, the so-called aglycones were thought to be able to pass through the gut wall. Hydrolysis only occurs in the colon by microorganisms, which at the same time degrade flavonoids. We performed a study to quantify absorption of various dietary forms of quercetin. To our surprise, the quercetin glycosides from onions were absorbed far better than the pure aglycone. Subsequent pharmacokinetic studies with dietary quercetin glycosides showed marked differences in absorption rate and bioavailability. Absorbed quercetin was eliminated only slowly from the blood.

The metabolism of flavonoids has been studied frequently in various animals, but very few data in humans are available. Two major sites of flavonoid metabolism are the liver and the colonic flora. There is evidence for Omethylation, sulfation and glucuronidation of hydroxyl groups in the liver. Bacterial ring fission of flavonoids occurs in the colon. The subsequent degradation products, phenolic acids, can be absorbed and are found in urine of animals. Quantitative data on metabolism are scarce.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aeschbacher HU, Meier H, Ruch E (1982) Nonmutagenicity in vivo of the food flavonol quercetin. Nutr Cancer 4: 90–98

    Article  PubMed  CAS  Google Scholar 

  • Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J (1995) Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15: 441–445

    CAS  Google Scholar 

  • Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of epidemiological evidence. Nutr Cancer 18: 1–29

    Article  PubMed  CAS  Google Scholar 

  • Goldbohm RA, van den Brandt PA, Hertog MGL, Brants HAM, van Poppel G (1995) Flavonoid intake and risk of cancer: a prospective cohort study. Am J Epidemiol 141 (Suppl): s61

    Google Scholar 

  • Griffiths LA (1982) Mammalian metabolism of flavonoids. In: The Flavonoids: Advances in Research ( Harborne J, Mabry T eds), London: Chapman and Hall, pp. 681–718

    Google Scholar 

  • Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229–234

    Article  PubMed  CAS  Google Scholar 

  • Hackett AM (1986) The metabolism of flavonoid compounds in mammals. In: Plant flavonoias in biology and medicine. Biochemical, pharmacological, structure-activity relationships ( Cody V, Middleton E, Harborne J eds), New York: Alan R. Liss, Inc., pp. 177–194

    Google Scholar 

  • Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344: 721–724

    Article  PubMed  CAS  Google Scholar 

  • Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40: 2379–2383

    Article  CAS  Google Scholar 

  • Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D (1993a) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007–1011

    Article  PubMed  CAS  Google Scholar 

  • Hertog MGL, Hollman PCH, van de Putte B (1993b) Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 41: 1242–1246

    CAS  Google Scholar 

  • Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D (1994) Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 22x: 175–184

    Article  PubMed  CAS  Google Scholar 

  • Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 155: 381–386

    Article  PubMed  CAS  Google Scholar 

  • Hertog MGL, Feskens EJM, Kromhout D (1997a) Antioxidant flavonols and coronary heart disease risk: ten year follow-up of the Zutphen Elderly Study. Lancet 349: 699

    Article  PubMed  CAS  Google Scholar 

  • Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D (1997b) Antioxidant flavonols and ischaemic heart disease in a Welsh population of men. The Caerphilly Study. Am J Clin Nutr 65: 1489–1494

    Google Scholar 

  • Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62: 1276–1282

    PubMed  CAS  Google Scholar 

  • Hollman PCH (1997) Determinants of the absorption of the dietary flavonoid quercetin in man. Wageningen: Thesis, Agricultural University

    Google Scholar 

  • Huang M-T, Ferraro T (1992) Phenolic compounds in food and cancer prevention. In: Phenolic compounds in food and their effects on health II. Antioxidants & cancer prevention ( Huang M-T, Ho C, Lee CY eds), Washington DC: American Chemical Society, pp. 8–34

    Chapter  Google Scholar 

  • Jha P, Flather M, Lonn E, Farkouh M, Yusuf S (1995) The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 123: 860–872

    PubMed  CAS  Google Scholar 

  • Kandaswami C, Middleton E (1994) Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Bio l366: 351–376

    Google Scholar 

  • Keli SO, Hertog MGL, Feskens EJM, Kromhout D (1996) Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen study. Arch Intern Med 156: 637–642

    Article  PubMed  CAS  Google Scholar 

  • Knekt P, Järvinen R, Reunanen A, Maatela J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312: 478–481

    Article  CAS  Google Scholar 

  • Kiihnau J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24: 117–191

    Google Scholar 

  • MacGregor JT, Wehr CM, Manners GD, Jurd L, Minkler JL, Carrano AV (1983) In vivo exposure to plant flavonols. Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutation Res 124: 255–270

    Article  PubMed  CAS  Google Scholar 

  • Middleton E, Kandaswami C (1994) The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: The Flavonoids: advances in research since 1986 (Harborne JB ed), London: Chapman & Hall, pp. 619–652

    Google Scholar 

  • Ness AR, Powles JW (1997) Fruit and vegetables, and cardiovascular disease: a review Int J Epidemiol 26: 1–13

    CAS  Google Scholar 

  • Rice-Evans CA, Miller NJ (1996) Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 24: 790–795

    PubMed  CAS  Google Scholar 

  • Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC (1996) Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125: 384–389

    PubMed  CAS  Google Scholar 

  • Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883–887

    Article  PubMed  CAS  Google Scholar 

  • Shaikh M, Martini S, Quiney JR, Baskerville P, La Ville AE, Browse NL, Duffield R, Turner PR, Lewis B (1988) Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis 69: 165–172

    Article  PubMed  CAS  Google Scholar 

  • Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915–924

    Article  PubMed  CAS  Google Scholar 

  • Steinmetz KA, Potter JD (1991) Vegetables, fruit and cancer. I. Epidemiology. Cancer Cause Control 2: 325–357

    Article  CAS  Google Scholar 

  • Sugimura T, Nagao M, Matsushima T, Yahagi T, Seino Y, Shirai A, Sawamura M, Natori S, Yoshibira K, Fukuoka M, Kuroyanagi M (1977) Mutagenicity of flavone derivatives. Proc Jpn Acad 53: 194–197

    Article  CAS  Google Scholar 

  • Ueno I, Nakano N, Hirono I (1983) Metabolic fate of (“C]quercetin in the ACI rat. Jpn J Exp Med 53: 41–50

    PubMed  CAS  Google Scholar 

  • Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52 (Suppl): 2085S - 2091S

    PubMed  CAS  Google Scholar 

  • de Whalley C, Rankin SM, Hoult JRS, Jessup W, Leake DS (199o) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Ph arms c of 39: 1743–1750

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hollman, P.C.H., Katan, M.B. (1998). Bioavailability and Health Effects of Dietary Flavonols in Man. In: Seiler, J.P., Autrup, J.L., Autrup, H. (eds) Diversification in Toxicology — Man and Environment. Archives of Toxicology, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46856-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-46856-8_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-46858-2

  • Online ISBN: 978-3-642-46856-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics